Previous close | 6.05 |
Open | 5.62 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 5.30 - 6.19 |
52-week range | 1.31 - 21.96 |
Volume | |
Avg. volume | 4,218 |
Market cap | N/A |
Beta (5Y monthly) | -1.38 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 2.63 (45.18%) |
Ex-dividend date | 01 Jun 2023 |
1y target est | N/A |
NEW YORK, NY, April 01, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Applied UV, Inc. (NASDAQ: AUVI) (the “Company”), a leader in smart building technology solutions, today announced the closing of its previously announced registered direct offering and concurrent private placement with institutional investors. The Company issued shares of common stock of the Company (“Common Stock”) and pre-funded warrants (“Pre-Funded Warrants”) in a registered direct offering. In a concurrent private placemen
NEW YORK, NY, March 27, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Applied UV, Inc. (NASDAQ: AUVI; AUVIP) (“Applied UV” or the “Company”), a leader in smart building technology solutions, today announced that it has entered into definitive agreements with institutional investors for the purchase and sale of common stock of the Company (“Common Stock”) and pre-funded warrants (“Pre-Funded Warrants”) in a registered direct offering. In a concurrent private placement, the Company also agreed to s
Applied UV, Inc. PURONet, Surgical Level of Disinfection Aligns with Company’s strategic focus on bringing to market state-of-the-art advanced disinfection systems NEW YORK, NY, March 11, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Applied UV, Inc. (“Applied UV” or the “Company”) (Nasdaq: AUVI), a leader in smart building technology solutions, today announced that its SteriLumen subsidiary has filed a new patent application with the United States Patent and Trademark Office (“USPTO”) entitled "